# Jasper Therapeutics, Inc.: Form 8-K, filed Feb 25, 2022

- Company: [Jasper Therapeutics, Inc.](/companies/jspr.md) (CIK 1788028)
- Form: 8-K
- Filed: 2022-02-25
- Accepted by EDGAR: Feb 24, 2022, 19:13 ET
- Period: 2022-02-24
- Accession: 0001213900-22-009272
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1788028/000121390022009272/ea156175-8k_jasper.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1788028/000121390022009272/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1788028/000121390022009272/ea156175-8k_jasper.htm

Filed Feb 25, 2022.
Source: SEC EDGAR, the filing index for accession 0001213900-22-009272. Last ingested by Listed: Nov 9, 2026, 17:50 ET. No prices; not investment advice.